Geode Capital Management, LLC Atossa Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,814,446 shares of ATOS stock, worth $2.79 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,814,446
Previous 2,769,684
1.62%
Holding current value
$2.79 Million
Previous $3.3 Million
29.8%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ATOS
# of Institutions
90Shares Held
26.5MCall Options Held
466KPut Options Held
91.8K-
Black Rock Inc. New York, NY9.2MShares$9.11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.6MShares$6.53 Million0.0% of portfolio
-
State Street Corp Boston, MA1.73MShares$1.71 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.31MShares$1.3 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL954KShares$944,6570.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $125M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...